摘要
扫描式葡萄糖监测(FGM)正改变着糖尿病患者血糖监测技术的格局。在2型糖尿病(T2DM)患者中,接受强化治疗和自我血糖监测下仍有严重低/高血糖或血糖波动大的T2DM患者是FGM受众群体中的重要组成部分。FGM技术革新性完全颠覆了传统指尖采血测定葡萄糖的管理模式。但目前国内外均无针对使用FGM的T2DM患者统一血糖管理模式的规范,临床应用中这一领域较为混乱。现结合实际工作经验,参考临床试验和指南推荐条目,试讨论使用FGM的T2DM患者的规范血糖管理模式,以期规范临床使用,发挥FGM对T2DM患者血糖监测的优势。
Flash glucose monitoring(FGM)is changing the pattern of blood glucose monitoring technology for diabetic patients.Among patients with type 2 diabetes mellitus(T2DM),T2DM patients with severe hypo/hyperglycemia or large blood glucose fluctuations under intensive treatment and self-monitoring of blood glucose are important parts of the FGM accepters.The innovation of FGM technology has completely subverted the traditional management model of fingertip blood sampling to determine glucose.However,there is currently no unified blood glucose management model for T2DM patients who use FGM at home and abroad,and this field is rather chaotic in clinical applications.This review combines our actual experience,results of clinical trials and recommended items in the guidelines,trying to discuss the standardized blood glucose management mode of T2DM patients using FGM,standardize clinical use and give full play to the advantages of FGM in blood glucose monitoring of T2DM patients.
作者
贺琼
薄佳琪
张佳鑫
李捷
刘子昂
尹建红
杨静
刘云峰
He Qiong;Bo Jiaqi;Zhang Jiaxin;Li Jie;Liu Ziang;Yin Jianhong;Yang Jing;Liu Yunfeng(Department of Endocrinology,the First Hospital of Shanxi Medical University,Taiyuan 030001,China;The First Clinical School,Shanxi Medical University,Taiyuan 030001,China;Department of Gastroenterology and Hepatology,the First Hospital of Shanxi Medical University,Taiyuan 030001,China;Shanxi Bethune Hospital&Shanxi Academy of Medical Sciences,Taiyuan 030001,China;The Third Clinical School,Shanxi Medical University,Taiyuan 030001,China)
出处
《国际内分泌代谢杂志》
2021年第4期348-351,371,共5页
International Journal of Endocrinology and Metabolism
基金
国家自然科学基金(81770776,82073909)
山西省回国留学人员科研资助项目(2020-172)
山西省研究生教育创新项目(2020SY258)。
关键词
扫描式葡萄糖监测
2型糖尿病
血糖管理
Flash glucose monitoring
Type 2 diabetes mellitus
Blood glucose management